U.S. stock futures were mostly higher this morning, with the Dow futures gaining around 0.1% on Tuesday.

Shares of Acelyrin, Inc. (NASDAQ:SLRN) fell sharply in today's pre-market trading.

ACELYRIN announced additional Phase 2 data and the Phase 3 program design for lonigutamab in Thyroid Eye Disease.

Acelyrin shares tumbled 15.4% to $2.95 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

• Cogent Biosciences, Inc. (NASDAQ:COGT) shares fell 13.2% to $7.00 in pre-market trading.
• ZJK Industrial Co., Ltd. (NASDAQ:ZJK) fell 12.2% to $10.55 in pre-market trading after jumping 32% on Monday.
• Alpha Teknova, Inc. (NASDAQ:TKNO) dipped 7.3% to $8.40 in pre-market trading following a 4% gain on Monday.
• Third Harmonic Bio, Inc. (NASDAQ:THRD) fell 6.8% to $10.41 in pre-market trading.
• Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) fell 3.7% to $7.52 in pre-market trading.
• NeuroPace, Inc. (NASDAQ:NPCE) fell 4.8% to $11.36 in pre-market trading.
• Tesla, Inc. (NASDAQ:TSLA) fell 1.7% to $404.26 in pre-market trading. Tesla on Monday reminisced about delivering the first Model 3 cars made at the company's gigafactory in Shanghai.

Now Read This:

• Wells Fargo Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts